Product Description
Taxonab 100mg Injection is a prescription-only cytotoxic (chemotherapy) medicine containing Paclitaxel, a taxane that stops cancer cells from dividing. It is used for ovarian cancer, breast cancer and non-small cell lung cancer, and is manufactured by Zydus. It must be prepared and administered only by trained healthcare professionals in a hospital or oncology centre.
Key Benefits
Taxane chemotherapy that stops cancer cell division and slows tumour growth
Prescribed for ovarian cancer, breast cancer and non-small cell lung cancer (NSCLC), as decided by the oncologist
Single-dose 100mg vial for intravenous infusion under medical supervision
Manufactured by Zydus, India
Hospital and oncology centre supply
Key Ingredients & Their Uses
Paclitaxel (100mg): a cytotoxic taxane that interferes with the normal breakdown of microtubules during cell division, so cancer cells cannot multiply and die.
How to Use
Administered only as an intravenous (IV) infusion by a doctor or trained healthcare professional in a medical setting.
Dose, schedule and number of cycles are decided by the oncologist based on the cancer type, body size and blood counts.
Not for self-administration.
Your doctor may give medicines before each infusion to reduce the risk of allergic reactions.
If a dose is missed, consult your doctor.
Technical Specifications
Brand: Taxonab
Product Name: Taxonab 100mg Injection
Product Type: Prescription Allopathic Medicine (Anticancer, Cytotoxic, Taxane)
Strength: 100mg
Net Quantity: 1 Vial (see flags for pack size)
Pack Type: Single-dose vial
Storage: 15°C to 25°C, protect from light
Suitable For: Adults (not recommended below 18 years), as prescribed by a doctor
Country of Origin: India
Manufacturer: Zydus